THURSDAY, Nov. 7, 2024 (HealthDay News) -- More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug ...
WASHINGTON, Oct 29 (Reuters) - The U.S. Food and Drug Administration on Wednesday said it is aiming to reduce the number of human clinical studies required for approval of certain biosimilar drugs and ...
The Trump administration’s latest effort to lower drug costs is expanding to biosimilars, medications that are highly similar to biologic drugs made with or isolated from living organisms such as ...
Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...
After popular pain med Tylenol came under fire from officials in the Trump administration for an alleged link to autism if used during pregnancy, the product's manufacturer is fighting back at a ...
Editor’s Note: The above video is from KXAN’s previous coverage on the demonstration at the rainbow crosswalk. AUSTIN (KXAN) — Austin Mayor Kirk Watson proposed that the city of Austin create a task ...
This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). Millions of men undergoing hair ...
The Department of Health & Human Services (HHS) has stepped up its efforts against soaring drug costs in the U.S., sending a newly proposed drug pricing rule for review at the White House. The White ...
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
Wolfers explained that for these unique medications, the economic leverage lies entirely with the manufacturer. “The administration’s theory of the case has always been American consumers have options ...
The White House announced on Thursday that a proposed drug pricing rule drafted by the Department of Health & Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) is currently ...
WASHINGTON — When President Donald Trump’s administration announced it would repurpose an old, generic drug as a new treatment for autism, it came as a surprise to many experts — including the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback